The efficacy and safety of thalidomide on the recurrence interval of continuous recurrent aphthous ulceration: A randomized controlled clinical trial.
Qingxiang ZengXueke ShiJin YangMiao YangWei ZhaoXiaoyi ZhaoJiahong ShiHongmei ZhouPublished in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2019)
Thalidomide had a long-term effect of extending the recurrence interval of continuous RAU.
Keyphrases